世界のダビガトラン市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Dabigatran Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5689 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、ダビガトランの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、カプセル、その他）、用途別市場規模（深部静脈血栓症、肺塞栓症、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ダビガトランの市場動向 ・企業の競争状況、市場シェア ・ダビガトランの種類別市場規模と予測2016-2027（錠剤、カプセル、その他） ・ダビガトランの用途別市場規模と予測2016-2027（深部静脈血栓症、肺塞栓症、その他） ・ダビガトランの北米市場規模2016-2027（アメリカ、カナダ） ・ダビガトランの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ダビガトランのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ダビガトランの中南米市場規模2016-2027（メキシコ、ブラジル） ・ダビガトランの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Bayer Healthcare、GlaxoSmithKline、Boehringer Ingelheim、Aspen Holdings、Bristol-Myers Squibb Company、Teva Pharmaceutical Industries） ・結論

Dabigatran is an innovative anticoagulant, a new generation of thin blood drugs, known as the best drug for prevention of stroke in the past 60 years.

Market Analysis and Insights: Global Dabigatran Market
The global Dabigatran market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Dabigatran market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Dabigatran market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Dabigatran market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Dabigatran market.

Global Dabigatran Scope and Market Size
Dabigatran market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dabigatran market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Tablets
Capsule
Others

Segment by Application
Deep Vein Thrombosis
Pulmonary Embolism
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Bayer Healthcare
GlaxoSmithKline
Boehringer Ingelheim
Aspen Holdings
Bristol-Myers Squibb Company
Teva Pharmaceutical Industries

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dabigatran Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tablets
1.2.3 Capsule
1.2.4 Others
1.3 Market by Application
1.3.1 Global Dabigatran Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Deep Vein Thrombosis
1.3.3 Pulmonary Embolism
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Dabigatran Market Perspective (2016-2027)
2.2 Dabigatran Growth Trends by Regions
2.2.1 Dabigatran Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Dabigatran Historic Market Share by Regions (2016-2021)
2.2.3 Dabigatran Forecasted Market Size by Regions (2022-2027)
2.3 Dabigatran Industry Dynamic
2.3.1 Dabigatran Market Trends
2.3.2 Dabigatran Market Drivers
2.3.3 Dabigatran Market Challenges
2.3.4 Dabigatran Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Dabigatran Players by Revenue
3.1.1 Global Top Dabigatran Players by Revenue (2016-2021)
3.1.2 Global Dabigatran Revenue Market Share by Players (2016-2021)
3.2 Global Dabigatran Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Dabigatran Revenue
3.4 Global Dabigatran Market Concentration Ratio
3.4.1 Global Dabigatran Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dabigatran Revenue in 2020
3.5 Dabigatran Key Players Head office and Area Served
3.6 Key Players Dabigatran Product Solution and Service
3.7 Date of Enter into Dabigatran Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Dabigatran Breakdown Data by Type
4.1 Global Dabigatran Historic Market Size by Type (2016-2021)
4.2 Global Dabigatran Forecasted Market Size by Type (2022-2027)

5 Dabigatran Breakdown Data by Application
5.1 Global Dabigatran Historic Market Size by Application (2016-2021)
5.2 Global Dabigatran Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Dabigatran Market Size (2016-2027)
6.2 North America Dabigatran Market Size by Type
6.2.1 North America Dabigatran Market Size by Type (2016-2021)
6.2.2 North America Dabigatran Market Size by Type (2022-2027)
6.2.3 North America Dabigatran Market Size by Type (2016-2027)
6.3 North America Dabigatran Market Size by Application
6.3.1 North America Dabigatran Market Size by Application (2016-2021)
6.3.2 North America Dabigatran Market Size by Application (2022-2027)
6.3.3 North America Dabigatran Market Size by Application (2016-2027)
6.4 North America Dabigatran Market Size by Country
6.4.1 North America Dabigatran Market Size by Country (2016-2021)
6.4.2 North America Dabigatran Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Dabigatran Market Size (2016-2027)
7.2 Europe Dabigatran Market Size by Type
7.2.1 Europe Dabigatran Market Size by Type (2016-2021)
7.2.2 Europe Dabigatran Market Size by Type (2022-2027)
7.2.3 Europe Dabigatran Market Size by Type (2016-2027)
7.3 Europe Dabigatran Market Size by Application
7.3.1 Europe Dabigatran Market Size by Application (2016-2021)
7.3.2 Europe Dabigatran Market Size by Application (2022-2027)
7.3.3 Europe Dabigatran Market Size by Application (2016-2027)
7.4 Europe Dabigatran Market Size by Country
7.4.1 Europe Dabigatran Market Size by Country (2016-2021)
7.4.2 Europe Dabigatran Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Dabigatran Market Size (2016-2027)
8.2 Asia-Pacific Dabigatran Market Size by Type
8.2.1 Asia-Pacific Dabigatran Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Dabigatran Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Dabigatran Market Size by Type (2016-2027)
8.3 Asia-Pacific Dabigatran Market Size by Application
8.3.1 Asia-Pacific Dabigatran Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Dabigatran Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Dabigatran Market Size by Application (2016-2027)
8.4 Asia-Pacific Dabigatran Market Size by Region
8.4.1 Asia-Pacific Dabigatran Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Dabigatran Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Dabigatran Market Size (2016-2027)
9.2 Latin America Dabigatran Market Size by Type
9.2.1 Latin America Dabigatran Market Size by Type (2016-2021)
9.2.2 Latin America Dabigatran Market Size by Type (2022-2027)
9.2.3 Latin America Dabigatran Market Size by Type (2016-2027)
9.3 Latin America Dabigatran Market Size by Application
9.3.1 Latin America Dabigatran Market Size by Application (2016-2021)
9.3.2 Latin America Dabigatran Market Size by Application (2022-2027)
9.3.3 Latin America Dabigatran Market Size by Application (2016-2027)
9.4 Latin America Dabigatran Market Size by Country
9.4.1 Latin America Dabigatran Market Size by Country (2016-2021)
9.4.2 Latin America Dabigatran Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Dabigatran Market Size (2016-2027)
10.2 Middle East & Africa Dabigatran Market Size by Type
10.2.1 Middle East & Africa Dabigatran Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Dabigatran Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Dabigatran Market Size by Type (2016-2027)
10.3 Middle East & Africa Dabigatran Market Size by Application
10.3.1 Middle East & Africa Dabigatran Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Dabigatran Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Dabigatran Market Size by Application (2016-2027)
10.4 Middle East & Africa Dabigatran Market Size by Country
10.4.1 Middle East & Africa Dabigatran Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Dabigatran Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Dabigatran Introduction
11.1.4 Pfizer Revenue in Dabigatran Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Bayer Healthcare
11.2.1 Bayer Healthcare Company Details
11.2.2 Bayer Healthcare Business Overview
11.2.3 Bayer Healthcare Dabigatran Introduction
11.2.4 Bayer Healthcare Revenue in Dabigatran Business (2016-2021)
11.2.5 Bayer Healthcare Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Dabigatran Introduction
11.3.4 GlaxoSmithKline Revenue in Dabigatran Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Details
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Dabigatran Introduction
11.4.4 Boehringer Ingelheim Revenue in Dabigatran Business (2016-2021)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Aspen Holdings
11.5.1 Aspen Holdings Company Details
11.5.2 Aspen Holdings Business Overview
11.5.3 Aspen Holdings Dabigatran Introduction
11.5.4 Aspen Holdings Revenue in Dabigatran Business (2016-2021)
11.5.5 Aspen Holdings Recent Development
11.6 Bristol-Myers Squibb Company
11.6.1 Bristol-Myers Squibb Company Company Details
11.6.2 Bristol-Myers Squibb Company Business Overview
11.6.3 Bristol-Myers Squibb Company Dabigatran Introduction
11.6.4 Bristol-Myers Squibb Company Revenue in Dabigatran Business (2016-2021)
11.6.5 Bristol-Myers Squibb Company Recent Development
11.7 Teva Pharmaceutical Industries
11.7.1 Teva Pharmaceutical Industries Company Details
11.7.2 Teva Pharmaceutical Industries Business Overview
11.7.3 Teva Pharmaceutical Industries Dabigatran Introduction
11.7.4 Teva Pharmaceutical Industries Revenue in Dabigatran Business (2016-2021)
11.7.5 Teva Pharmaceutical Industries Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Dabigatran Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tablets
Table 3. Key Players of Capsule
Table 4. Key Players of Others
Table 5. Global Dabigatran Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Dabigatran Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Dabigatran Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Dabigatran Market Share by Regions (2016-2021)
Table 9. Global Dabigatran Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Dabigatran Market Share by Regions (2022-2027)
Table 11. Dabigatran Market Trends
Table 12. Dabigatran Market Drivers
Table 13. Dabigatran Market Challenges
Table 14. Dabigatran Market Restraints
Table 15. Global Dabigatran Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Dabigatran Market Share by Players (2016-2021)
Table 17. Global Top Dabigatran Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dabigatran as of 2020)
Table 18. Ranking of Global Top Dabigatran Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Dabigatran Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Dabigatran Product Solution and Service
Table 22. Date of Enter into Dabigatran Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Dabigatran Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Dabigatran Revenue Market Share by Type (2016-2021)
Table 26. Global Dabigatran Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Dabigatran Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Dabigatran Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Dabigatran Revenue Market Share by Application (2016-2021)
Table 30. Global Dabigatran Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Dabigatran Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Dabigatran Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Dabigatran Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Dabigatran Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Dabigatran Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Dabigatran Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Dabigatran Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Dabigatran Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Dabigatran Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Dabigatran Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Dabigatran Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Dabigatran Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Dabigatran Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Dabigatran Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Dabigatran Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Dabigatran Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Dabigatran Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Dabigatran Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Dabigatran Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Dabigatran Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Dabigatran Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Dabigatran Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Dabigatran Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Dabigatran Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Dabigatran Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Dabigatran Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Dabigatran Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Dabigatran Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Dabigatran Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Dabigatran Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Dabigatran Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Dabigatran Product
Table 65. Pfizer Revenue in Dabigatran Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Bayer Healthcare Company Details
Table 68. Bayer Healthcare Business Overview
Table 69. Bayer Healthcare Dabigatran Product
Table 70. Bayer Healthcare Revenue in Dabigatran Business (2016-2021) & (US$ Million)
Table 71. Bayer Healthcare Recent Development
Table 72. GlaxoSmithKline Company Details
Table 73. GlaxoSmithKline Business Overview
Table 74. GlaxoSmithKline Dabigatran Product
Table 75. GlaxoSmithKline Revenue in Dabigatran Business (2016-2021) & (US$ Million)
Table 76. GlaxoSmithKline Recent Development
Table 77. Boehringer Ingelheim Company Details
Table 78. Boehringer Ingelheim Business Overview
Table 79. Boehringer Ingelheim Dabigatran Product
Table 80. Boehringer Ingelheim Revenue in Dabigatran Business (2016-2021) & (US$ Million)
Table 81. Boehringer Ingelheim Recent Development
Table 82. Aspen Holdings Company Details
Table 83. Aspen Holdings Business Overview
Table 84. Aspen Holdings Dabigatran Product
Table 85. Aspen Holdings Revenue in Dabigatran Business (2016-2021) & (US$ Million)
Table 86. Aspen Holdings Recent Development
Table 87. Bristol-Myers Squibb Company Company Details
Table 88. Bristol-Myers Squibb Company Business Overview
Table 89. Bristol-Myers Squibb Company Dabigatran Product
Table 90. Bristol-Myers Squibb Company Revenue in Dabigatran Business (2016-2021) & (US$ Million)
Table 91. Bristol-Myers Squibb Company Recent Development
Table 92. Teva Pharmaceutical Industries Company Details
Table 93. Teva Pharmaceutical Industries Business Overview
Table 94. Teva Pharmaceutical Industries Dabigatran Product
Table 95. Teva Pharmaceutical Industries Revenue in Dabigatran Business (2016-2021) & (US$ Million)
Table 96. Teva Pharmaceutical Industries Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dabigatran Market Share by Type: 2020 VS 2027
Figure 2. Tablets Features
Figure 3. Capsule Features
Figure 4. Others Features
Figure 5. Global Dabigatran Market Share by Application: 2020 VS 2027
Figure 6. Deep Vein Thrombosis Case Studies
Figure 7. Pulmonary Embolism Case Studies
Figure 8. Others Case Studies
Figure 9. Dabigatran Report Years Considered
Figure 10. Global Dabigatran Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Dabigatran Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Dabigatran Market Share by Regions: 2020 VS 2027
Figure 13. Global Dabigatran Market Share by Regions (2022-2027)
Figure 14. Global Dabigatran Market Share by Players in 2020
Figure 15. Global Top Dabigatran Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dabigatran as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Dabigatran Revenue in 2020
Figure 17. Global Dabigatran Revenue Market Share by Type (2016-2021)
Figure 18. Global Dabigatran Revenue Market Share by Type (2022-2027)
Figure 19. North America Dabigatran Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Dabigatran Market Share by Type (2016-2027)
Figure 21. North America Dabigatran Market Share by Application (2016-2027)
Figure 22. North America Dabigatran Market Share by Country (2016-2027)
Figure 23. United States Dabigatran Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Dabigatran Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Dabigatran Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Dabigatran Market Share by Type (2016-2027)
Figure 27. Europe Dabigatran Market Share by Application (2016-2027)
Figure 28. Europe Dabigatran Market Share by Country (2016-2027)
Figure 29. Germany Dabigatran Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Dabigatran Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Dabigatran Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Dabigatran Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Dabigatran Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Dabigatran Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Dabigatran Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Dabigatran Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Dabigatran Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Dabigatran Market Share by Region (2016-2027)
Figure 39. China Dabigatran Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Dabigatran Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Dabigatran Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Dabigatran Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Dabigatran Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Dabigatran Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Dabigatran Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Dabigatran Market Share by Type (2016-2027)
Figure 47. Latin America Dabigatran Market Share by Application (2016-2027)
Figure 48. Latin America Dabigatran Market Share by Country (2016-2027)
Figure 49. Mexico Dabigatran Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Dabigatran Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Dabigatran Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Dabigatran Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Dabigatran Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Dabigatran Market Share by Country (2016-2027)
Figure 55. Turkey Dabigatran Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Dabigatran Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Dabigatran Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Dabigatran Business (2016-2021)
Figure 59. Bayer Healthcare Revenue Growth Rate in Dabigatran Business (2016-2021)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Dabigatran Business (2016-2021)
Figure 61. Boehringer Ingelheim Revenue Growth Rate in Dabigatran Business (2016-2021)
Figure 62. Aspen Holdings Revenue Growth Rate in Dabigatran Business (2016-2021)
Figure 63. Bristol-Myers Squibb Company Revenue Growth Rate in Dabigatran Business (2016-2021)
Figure 64. Teva Pharmaceutical Industries Revenue Growth Rate in Dabigatran Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

---